FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3210244067> ?p ?o ?g. }

• W3210244067 abstract "To present a treatment clinical trial, involving three types of treatment for chronic developmental stuttering (CDS), to verify whether they present indicators and sufficient information to establish an effective and safe benefit-risk relationship.The study included 252 children between 2 and 12 years old, who underwent assessment and treatment for CDS. Among the selected children, 93 met the established inclusion criteria. After obtaining the scores for the risk of CDS (Protocol for the Risk of Developmental Stuttering), all children were assessed according to their fluency profile and the severity level of stuttering. The children underwent treatment for CDS Green, Yellow and Red Programs. The treatment chosen for each child was based on the analysis of the risk for CDS.All therapeutic programs presented positive results in the post-treatment assessment considering the analyzed parameters, with the exception of word repetition, sound prolongation at the end of words, and intrusion of sounds/word segments.The tested therapeutic programs - green, yellow, and red - were efficient for most of the participants. The direct intervention used in the Red Program was highly efficient in promoting fluent speech. This result suggests that for most of the patients with a higher risk of developing the chronic form of stuttering, the use of specific fluency promotion techniques is indicated.Delinear um ensaio clínico de tratamento – em três modalidades – que verificasse se os tramentos testados para a gagueira crônica do desenvolvimento (GCD) apresentam indicadores que permitam reunir informações para a continuidade da sua aplicação, estabelecendo uma relação benefício-risco eficaz e segura.Para a realização do estudo foram analisadas 252 crianças, com idades entre 2 e 12 anos, que realizaram avaliação e tratamento para a GCD. Dentre as crianças atendidas, 93 cumpriram todos os critérios de elegibilidade. Após a obtenção dos escores de risco para GCD (Protocolo de Risco para a Gagueira do Desenvolvimento) todas as crianças foram avaliadas segundo seu perfil da fluência e grau de gravidade da gagueira. Foram aplicados os tratamentos para GCD: Programa Verde; Programa Amarelo e Programa Vermelho. A determinação do tratamento mais indicado para cada criança foi baseada na análise do grau de risco para a GCD.Todos os programas terapeuticos apresentaram resultados de melhora pós-tratamento consistentes nos segmentos analisados com exceção de: repetição de palavras; prolongamentos no final das palavras e intrusão de sons/segmentos.Os programas terapêuticos testados – verde, amarelo e vermelho – foram eficientes para a ampla maioria dos participantes. A intervenção direta, aplicada no Programa Vermelho, foi altamente eficiente para a promoção da fala fluente, indicando que para os casos com maior índice de cronicidade a aplicação de técnicas específicas é indicada." @default.
• W3210244067 created "2021-11-08" @default.
• W3210244067 creator A5003420113 @default.
• W3210244067 creator A5032552829 @default.
• W3210244067 creator A5074272390 @default.
• W3210244067 creator A5084211316 @default.
• W3210244067 date "2022-01-01" @default.
• W3210244067 modified "2023-09-23" @default.
• W3210244067 title "Ensaio clínico de tratamento – em três modalidades – para crianças com distúrbios da fluência e gagueira" @default.
• W3210244067 cites W1528784932 @default.
• W3210244067 cites W2025548258 @default.
• W3210244067 cites W2032541700 @default.
• W3210244067 cites W2083526227 @default.
• W3210244067 cites W2115588139 @default.
• W3210244067 cites W2118097118 @default.
• W3210244067 cites W2162657386 @default.
• W3210244067 cites W2582213403 @default.
• W3210244067 cites W2591697616 @default.
• W3210244067 cites W2595905226 @default.
• W3210244067 cites W2751746797 @default.
• W3210244067 cites W2783230424 @default.
• W3210244067 cites W2783650358 @default.
• W3210244067 cites W2886614558 @default.
• W3210244067 cites W2897577627 @default.
• W3210244067 cites W2898616374 @default.
• W3210244067 cites W4235092737 @default.
• W3210244067 doi "https://doi.org/10.1590/2317-1782/20212020264" @default.
• W3210244067 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34705998" @default.
• W3210244067 hasPublicationYear "2022" @default.
• W3210244067 type Work @default.
• W3210244067 sameAs 3210244067 @default.
• W3210244067 citedByCount "0" @default.
• W3210244067 crossrefType "journal-article" @default.
• W3210244067 hasAuthorship W3210244067A5003420113 @default.
• W3210244067 hasAuthorship W3210244067A5032552829 @default.
• W3210244067 hasAuthorship W3210244067A5074272390 @default.
• W3210244067 hasAuthorship W3210244067A5084211316 @default.
• W3210244067 hasBestOaLocation W32102440671 @default.
• W3210244067 hasConcept C145420912 @default.
• W3210244067 hasConcept C15744967 @default.
• W3210244067 hasConcept C187212893 @default.
• W3210244067 hasConcept C2777413886 @default.
• W3210244067 hasConcept C2781371259 @default.
• W3210244067 hasConcept C548259974 @default.
• W3210244067 hasConcept C71924100 @default.
• W3210244067 hasConceptScore W3210244067C145420912 @default.
• W3210244067 hasConceptScore W3210244067C15744967 @default.
• W3210244067 hasConceptScore W3210244067C187212893 @default.
• W3210244067 hasConceptScore W3210244067C2777413886 @default.
• W3210244067 hasConceptScore W3210244067C2781371259 @default.
• W3210244067 hasConceptScore W3210244067C548259974 @default.
• W3210244067 hasConceptScore W3210244067C71924100 @default.
• W3210244067 hasIssue "2" @default.
• W3210244067 hasLocation W32102440671 @default.
• W3210244067 hasLocation W32102440672 @default.
• W3210244067 hasOpenAccess W3210244067 @default.
• W3210244067 hasPrimaryLocation W32102440671 @default.
• W3210244067 hasRelatedWork W2010265499 @default.
• W3210244067 hasRelatedWork W2022288375 @default.
• W3210244067 hasRelatedWork W2044030344 @default.
• W3210244067 hasRelatedWork W2049411630 @default.
• W3210244067 hasRelatedWork W2050633151 @default.
• W3210244067 hasRelatedWork W2069040010 @default.
• W3210244067 hasRelatedWork W2748952813 @default.
• W3210244067 hasRelatedWork W2837098789 @default.
• W3210244067 hasRelatedWork W2899084033 @default.
• W3210244067 hasRelatedWork W4243027195 @default.
• W3210244067 hasVolume "34" @default.
• W3210244067 isParatext "false" @default.
• W3210244067 isRetracted "false" @default.
• W3210244067 magId "3210244067" @default.
• W3210244067 workType "article" @default.